Alesta Therapeutics Funding: $67M Raised, Series A (2025)
Alesta Therapeutics is a Biotech company based in Leiden, Netherlands. It has raised $67M in total funding. Latest round: Series A.
Alesta Therapeutics funding overview
Alesta Therapeutics is a Biotech company based in Leiden, Netherlands. Alesta Therapeutics has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Alesta Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Frazier Life Sciences, Droia Ventures, Novartis Venture Fund, RTW Investments, RV Invest, Thuja Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Alesta Therapeutics funding
How much has Alesta Therapeutics raised?
Alesta Therapeutics has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Alesta Therapeutics?
Frazier Life Sciences, Droia Ventures, Novartis Venture Fund, RTW Investments, RV Invest, Thuja Capital are named among the investors backing Alesta Therapeutics.
What was the latest Alesta Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2025.
Where is Alesta Therapeutics based?
Alesta Therapeutics is based in Leiden, Netherlands.
What sector does Alesta Therapeutics operate in?
Alesta Therapeutics is tracked under Biotech from Leiden, Netherlands, with $67M in disclosed funding.
When did Alesta Therapeutics last raise?
The last disclosed Alesta Therapeutics round closed in January 2025 at Series A.
We update the Alesta Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Leiden and their backers are listed below.
